Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor

Blood

Volumn 116, Issue 4, 2010, Pages 640-648

  McKinnon, Thomas A J ^a   Goode, Elizabeth C ^a   Birdsey, Graeme M ^b   Nowak, Agata A ^a   Chan, Alain C K ^a   Lane, David A ^a   Laffan, Michael A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; VON WILLEBRAND FACTOR; BACTERIAL ANTIGEN; H ANTIGEN; MUTANT PROTEIN; POLYSACCHARIDE;

ARTICLE; CELL LYSATE; DISULFIDE BOND; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; AMINO ACID SUBSTITUTION; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; GENE EXPRESSION; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN PROCESSING; PROTEIN TRANSPORT; SECRETION; TISSUE DISTRIBUTION;

AMINO ACID SUBSTITUTION; ANTIGENS, BACTERIAL; CATALYTIC DOMAIN; CELLS, CULTURED; GENE EXPRESSION; GLYCOSYLATION; HUMANS; MODELS, BIOLOGICAL; MUTANT PROTEINS; MUTATION; POLYSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION; VON WILLEBRAND FACTOR;

EID: 77956036035     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-02-267450     Document Type: Article

References (39)

1. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395-424.
2. Nogami K, Shima M, Nishiya K, et al. A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C-catalyzed inactivation. Blood. 2002;99(11):3993-3998.
3. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217-246.
4. Katsumi A, Tuley EA, Bodo I, Sadler JE. Localization of disulfide bonds in the cystine knot domain of human von Willebrand factor. J Biol Chem. 2000;275(33):25585-25594.
5. Voorberg J, Fontijn R, van Mourik JA, Pannekoek H. Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization. EMBO J. 1990;9(3):797-803.
6. de Romeuf C, Mazurier C. Heparin binding assay of von Willebrand factor (vWF) in plasma milieu - evidence of the importance of the multimerization degree of vWF. Thromb Haemost. 1993;69(5):436-440.
7. Titani K, Kumar S, Takio K, et al. Amino acid sequence of human von Willebrand factor. Biochemistry. 1986;25(11):3171-3184. (Pubitemid 16056960)
8. Samor B, Mazurier C, Goudemand M, et al. Preliminary results on the carbohydrate moiety of factor VIII/von Willebrand factor (FVIII/vWf). Thromb Res. 25(1-2):81-89, 1982. (Pubitemid 12185143)
9. Miletich JP, Broze GJ, Jr. Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. J Biol Chem. 1990;265(19):11397-11404.
10. Gavel Y, von Heijne G. Sequence differences between glycosylated and non-glycosylated Asn-XThr/ Ser acceptor sites: implications for protein engineering. Protein Eng. 1990;3(5):433-442. (Pubitemid 20201068)
11. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 1985;54:631-664.
12. Moremen KW, Trimble RB, Herscovics A. Glycosidases of the asparagine-linked oligosaccharide processing pathway. Glycobiology. 1994;4(2):113-125.
13. Spiro RG, Zhu Q, Bhoyroo V, Soling HD. Definition of the lectin-like properties of the molecular chaperone, calreticulin, and demonstration of its copurification with endomannosidase from rat liver Golgi. J Biol Chem. 1996;271(19):11588-11594.
14. Ware FE, Vassilakos A, Peterson PA, et al. The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. J Biol Chem. 1995;270(9):4697-4704.
15. Oliver JD, van der Wal FJ, Bulleid NJ, High S. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science. 1997;275(5296):86-88. (Pubitemid 27020314)
16. Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem. 1992;267(13):8723-8731.
17. Mitra N, Sinha S, Ramya TN, Surolia A. N-linked oligosaccharides as outfitters for glycoprotein folding, form and function. Trends Biochem Sci. 2006;31(3):156-163.
18. Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science. 2001;291(5512):2364-2369.
19. McKinnon TA, Chion AC, Millington AJ, Lane DA, Laffan MA. N-linked glycosylation of VWF modulates its interaction with ADAMTS13. Blood. 2008;111(6):3042-3049.
20. Geiser M, Cebe R, Drewello D, Schmitz R. Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase. Biotechniques. 2001;31(1):88-90, 92.
21. Bodó I, Katsumi A, Tuley EA, et al. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. Blood. 2001;98(10):2973-2979.
22. Xie L, Chesterman CN, Hogg PJ. Control of von Willebrand factor multimer size by thrombospondin-1. J Exp Med. 2001;193(12):1341-1349.
23. Wagner DD, Mayadas T, Marder VJ. Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor. J Cell Biol. 1986;102(4):1320-1324.
24. Jacob GS. Glycosylation inhibitors in biology and medicine. Curr Opin Struct Biol. 1995;5(5):605-611.
25. Nossent AY, VAN Marion V, VAN Tilburg NH, et al. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis. J Thromb Haemost. 2006;4(12):2556-2562.
26. Michaux G, Hewlett LJ, Messenger SL, et al. Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor. Blood. 2003;102(7):2452-2458.
27. O'Connor SE, Pohlmann J, Imperiali B, Saskiawan I, Yamamoto K. Probing the effect of the outer saccharide residues of N-linked glycans on peptide conformation. J Am Chem Soc. 2001;123(25):6187-6188. (Pubitemid 32888491)
28. Mirazimi A, Svensson L. Carbohydrates facilitate correct disulfide bond formation and folding of rotavirus VP7. J Virol. 1998;72(5):3887-3892. (Pubitemid 28188689)
29. Choi H, Aboulfatova K, Pownall HJ, Cook R, Dong JF. Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor. J Biol Chem. 2007;282(49):35604-35611.
30. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000;10(12):524-530.
31. Molinari M, Helenius A. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science. 2000;288(5464):331-333. (Pubitemid 30226193)
32. Allen S, Goodeve AC, Peake IR, Daly ME. Endoplasmic reticulum retention and prolonged association of a von Willebrand's disease-causing von Willebrand factor variant with ERp57 and calnexin. Biochem Biophys Res Commun. 2001;280(2):448-453.
33. Bell SL, Xu G, Khatri IA, et al. N-linked oligosaccharides play a role in disulphide-dependent dimerization of intestinal mucin Muc2. Biochem J. 2003;373(Pt 3):893-900.
34. Feng W, Matzuk MM, Mountjoy K, et al. The asparagine-linked oligosaccharides of the human chorionic gonadotropin beta subunit facilitate correct disulfide bond pairing. J Biol Chem. 1995;270(20):11851-11859.
35. Imperiali B, Hendrickson TL. Asparagine-linked glycosylation: specificity and function of oligosaccharyl transferase. Bioorg Med Chem. 1995;3(12):1565-1578. (Pubitemid 26022435)
36. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood. 2007;109(1):145-154. (Pubitemid 46053055)
37. Eikenboom JC, Ploos van Amstel HK, Reitsma PH, Briet E. Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA. Thromb Haemost. 1992;68(4):448-454.
38. Haberichter SL, Budde U, Obser T, et al. The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF. Blood. 2010;115(22)4580-4587.
39. Zhang Q, Zhou YF, Zhang CZ, et al. Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A. 2009;106(23):9226-9231.